Syndax Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Syndax Pharmaceuticals

08/05/2024 14:32

* Syndax Pharmaceuticals Inc  SNDX.OQ  reported a quarterly
adjusted loss of 85 cents​​ per share for the quarter ended in
March, lower than the same quarter last year, when the company
reported EPS of -59 cents.  The mean expectation of
eleven analysts for the quarter was for a loss of 98 cents per
share. Wall Street expected results to range from $-1.11 to -90
cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Syndax Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 85 cents​.
    * The company reported a quarterly loss of $72.4 million.
    * Syndax Pharmaceuticals Inc shares had fallen by 2.6% this
quarter and gained 7.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 13.6%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Syndax
Pharmaceuticals Inc is $35.00 
This summary was machine generated from LSEG data May 8 at 01:32
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.98          -0.85          Beat
 Dec. 31 2023      -0.99          -1.00          Missed
 Sep. 30 2023      -0.80          -0.73          Beat
 Jun. 30 2023      -0.73          -0.64          Beat